CARDINAL HEALTH INC (CAH)

US14149Y1082 - Common Stock

118.28  +1.28 (+1.09%)

After market: 118.28 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
181.364B
11.63%
205.012B
13.04%
226.827B
10.64%
222.433B
-1.94%
240.614B
8.17%
257.876B
7.17%
274.1B
6.29%
298.33B
8.84%
EBITDA
YoY % growth
2.369B
-8.88%
2.466B
4.09%
2.86B
15.98%
3.186B
11.40%
3.473B
9.01%
3.72B
7.11%
N/AN/A
EBIT
YoY % growth
1.677B
-7.71%
1.774B
5.78%
2.15B
21.20%
2.566B
19.35%
2.832B
10.37%
3.099B
9.43%
3.169B
2.26%
3.284B
3.63%
Operating Margin
0.92%0.87%0.95%1.15%1.18%1.20%1.16%1.10%
EPS
YoY % growth
5.06
-16.78%
5.81
14.82%
7.47
28.57%
7.92
5.97%
8.78
10.97%
9.68
10.16%
10.43
7.77%
11.12
6.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.76
-3.16%
2.22
6.95%
2.04
10.83%
2.01
6.68%
2.02
14.86%
2.41
8.38%
2.25
10.11%
2.17
8.02%
2.24
10.76%
2.74
13.73%
2.43
8.40%
Revenue
Q2Q % growth
54.43B
-5.25%
54.17B
-1.35%
59.951B
0.14%
57.471B
9.94%
59.893B
10.04%
58.487B
7.97%
64.64B
7.82%
65.24B
13.52%
65.695B
9.69%
63.695B
8.90%
72.882B
12.75%
EBITDA
Q2Q % growth
718.77M
-15.14%
858.74M
-23.67%
804.46M
-35.75%
815.18M
10.31%
813.56M
13.19%
928.21M
8.09%
881.54M
9.58%
882.44M
8.25%
833.57M
2.46%
971.1M
4.62%
959.41M
8.83%
EBIT
Q2Q % growth
580M
16.00%
708.82M
17.94%
654.04M
20.67%
662.01M
18.85%
650.96M
12.23%
756.93M
6.79%
686.65M
4.99%
692.37M
4.59%
715.83M
9.97%
867.3M
14.58%
764.65M
11.36%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
1.88
8.67%
1.630.2515.13%
Q4 2024
Q2Q % growth
1.84
18.71%
1.760.084.62%
Q3 2024
Q2Q % growth
2.08
19.54%
1.970.115.55%
Q2 2024
Q2Q % growth
1.82
37.88%
1.620.2012.64%
Q1 2024
Q2Q % growth
1.73
44.17%
1.420.3121.95%
Q4 2023
Q2Q % growth
1.55
47.62%
1.510.042.66%
Q3 2023
Q2Q % growth
1.74
20.00%
1.500.2415.83%
Q2 2023
Q2Q % growth
1.32
3.94%
1.150.1714.85%
Q1 2023
Q2Q % growth
1.20
-6.98%
0.950.2526.10%
Q4 2022
Q2Q % growth
1.05
-19.23%
1.19-0.14-11.53%
Q3 2022
Q2Q % growth
1.45
-5.23%
1.54-0.09-5.87%
Q2 2022
Q2Q % growth
1.27
-27.01%
1.240.032.45%
Q1 2022
Q2Q % growth
1.29
-14.57%
1.34-0.05-3.68%
Q4 2021
Q2Q % growth
1.30
25.00%
1.210.097.29%
Q3 2021
Q2Q % growth
1.53
-5.56%
1.57-0.04-2.38%
Q2 2021
Q2Q % growth
1.74
14.47%
1.460.2819.40%
Q1 2021
Q2Q % growth
1.51
18.90%
1.140.3731.93%
Q4 2020
Q2Q % growth
1.04
-6.31%
0.930.1112.43%
Q3 2020
Q2Q % growth
1.62
1.89%
1.450.1711.94%
Q2 2020
Q2Q % growth
1.52
17.83%
1.230.2923.28%
Q1 2020
Q2Q % growth
1.27
-1.55%
1.110.1614.87%
Q4 2019
Q2Q % growth
1.11
9.90%
0.940.1718.32%
Q3 2019
Q2Q % growth
1.59
14.39%
1.440.1510.33%
Q2 2019
Q2Q % growth
1.29
-14.57%
1.100.1917.41%
Q1 2019
Q2Q % growth
1.29
18.35%
1.090.2018.69%
Q4 2018
Q2Q % growth
1.01 0.940.077.29%
Q3 2018
Q2Q % growth
1.39 1.53-0.14-8.95%
Q2 2018
Q2Q % growth
1.51 1.170.3429.52%
Q1 2018
Q2Q % growth
1.09 1.010.087.81%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
52.277B
-4.54%
51.404B873M1.70%
Q4 2024
Q2Q % growth
59.867B
12.00%
59.285B582M0.98%
Q3 2024
Q2Q % growth
54.911B
8.76%
56.615B-1.704B-3.01%
Q2 2024
Q2Q % growth
57.445B
11.61%
57.583B-138M-0.24%
Q1 2024
Q2Q % growth
54.763B
10.40%
55.306B-543M-0.98%
Q4 2023
Q2Q % growth
53.453B
13.57%
53.246B207M0.39%
Q3 2023
Q2Q % growth
50.487B
12.60%
50.206B281M0.56%
Q2 2023
Q2Q % growth
51.469B
13.23%
51.251B218M0.43%
Q1 2023
Q2Q % growth
49.603B
12.82%
48.668B935M1.92%
Q4 2022
Q2Q % growth
47.065B
10.52%
45.161B1.904B4.22%
Q3 2022
Q2Q % growth
44.836B
14.16%
43.591B1.245B2.86%
Q2 2022
Q2Q % growth
45.457B
9.43%
46.028B-571M-1.24%
Q1 2022
Q2Q % growth
43.968B
12.55%
42.352B1.616B3.82%
Q4 2021
Q2Q % growth
42.586B
16.07%
40.828B1.758B4.31%
Q3 2021
Q2Q % growth
39.275B
0.30%
40.494B-1.219B-3.01%
Q2 2021
Q2Q % growth
41.541B
4.55%
41.852B-311M-0.74%
Q1 2021
Q2Q % growth
39.065B
4.62%
38.559B506M1.31%
Q4 2020
Q2Q % growth
36.689B
-1.78%
37.04B-351M-0.95%
Q3 2020
Q2Q % growth
39.157B
11.15%
37.316B1.841B4.93%
Q2 2020
Q2Q % growth
39.735B
5.29%
39.826B-91M-0.23%
Q1 2020
Q2Q % growth
37.341B
6.04%
37.115B226M0.61%
Q4 2019
Q2Q % growth
37.353B
5.67%
37.183B170M0.46%
Q3 2019
Q2Q % growth
35.228B
4.74%
35.547B-319M-0.90%
Q2 2019
Q2Q % growth
37.74B
7.26%
36.46B1.28B3.51%
Q1 2019
Q2Q % growth
35.213B
7.88%
33.991B1.222B3.60%
Q4 2018
Q2Q % growth
35.349B 34.726B623M1.79%
Q3 2018
Q2Q % growth
33.633B 33.786B-153M-0.45%
Q2 2018
Q2Q % growth
35.186B 35.001B185M0.53%
Q1 2018
Q2Q % growth
32.641B 33.815B-1.174B-3.47%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.13% 0.74% 2.74%
Revenue0% 0.9% 0.66% 1.67%